News - Page 6 of 8 - Cyclotek

Cyclotek improving diagnostic accuracy in Prostate Cancer

Posted on: 06 August 2017Company

Cyclotek, GE Healthcare and Macquarie University take-on prostate cancer
read More
ASAN Medical Centre and Duchembio, Korea, licence DAT PET tracer for Parkinson’s to Cyclotek

Posted on: 05 July 2017Research

ASAN Medical Center and Duchembio Co. Ltd. announce Strategic Partnership with Cyclotek for E
read More
Cyclotek appoints new Director

Posted on: 10 June 2017Company

Doug Cubbin appointed to the Cyclotek board
read More
Non-inferiority study of DCFPyL and Ga-68 prostate tracer published

Posted on: 08 January 2017Uncategorized

Our data suggest that 18F-DCFPyL is non-inferior to 68Ga-PSMA-HBED-CC
read More
Results of cardiac amyloidosis study with FBB published

Posted on: 08 January 2017Uncategorized

In February 2016, we reported that a team at Princess Alexandra Hospital was using F18-Florbe
read More
4th Theranostics World Congress 2016

Posted on: 20 August 2016Company

Theranostics World Congress Melbourne, Australia. November 7th to 9th 2016
read More

© 2024 Cyclotek. All rights reserved

[contact-form-7 id=”714″ title=”Update Form”]